Different doors. One shared refusal to accept neglect.
Back a portfolio moving from market entry and clinical validation to platform science and local manufacture.
Help generate the evidence and infrastructure required to move neglected problems toward care. Our intended impact is ambitious. Our claims will remain disciplined. Product-specific outcomes will be published only when the relevant bench, safety, usability and clinical evidence supports them.
of women aged 15–49 globally were living with anaemia in 2023. (UN SDG Report / WHO estimates)
is the reported prevalence range for dysmenorrhoea across studies. (Ju et al., 2014)
studied perineal techniques in nearly 13,700 women—yet key outcomes remain under-reported. (Cochrane, 2024)
is the WHO-recommended early-treatment window for eligible intubated preterm newborns with RDS. (WHO preterm infant guidance)
Investors
Back a portfolio moving from market entry and clinical validation to platform science and local manufacture.
Grant funders
Help generate the evidence and infrastructure required to move neglected problems toward care.
Stage Gates & Capital Opportunities
Track how each innovation advances from frontline insight to bench testing, clinical validation, and cleanroom scale.
Waridi™
Perineal protectionClinical study preparation and regulatory engagement
Zawadi™
Earlier iron insightPrototype build, calibration and clinical feasibility work
WarmEase™
Dysmenorrhoea reliefProduct verification, manufacturing readiness and market introduction
Vaginal Formulations
Platform scienceFormulation optimisation and preclinical characterisation
SawaSurf™
Neonatal respiratory careFeasibility, process development and preclinical planning
Request Diligence Access or Schedule an Introduction
Direct access to our leadership team, financial models, clinical protocols, and stage-gate progression dossiers.
Our Standard
Affordable for Kirehe. Acceptable anywhere else. We build for world-class quality, rigorous evidence, and real affordability at the same time.
All non-public disclosures are governed under standard mutual confidentiality agreements.